Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
May 11, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, May 10, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
May 05, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Audited full year 2022 annual financial figures due to be reported by end of May 2023 Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage...
Global Ophthalmic Drops Market Research Report 2023: Sector is Projected to Reach $1.9 Billion in 2030 at a CAGR of $7.09%
May 02, 2023 10:33 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmic Drops Market Research Report by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops,...
Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report
April 28, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Ad hoc announcement pursuant to Art. 53 LR Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report Basel, Switzerland, 28...
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
April 21, 2023 09:05 ET
|
Doheny Eye Institute
PASADENA, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that more than 30 of its scientists and...
Global Macular Degeneration Treatment Market Report 2023: Major Players Include Novartis, Bausch Health Companies, Regenxbio, F Hoffmann-La Roche and Regeneron Pharmaceuticals
March 23, 2023 11:03 ET
|
Research and Markets
Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Global Retinal Disorder Treatment Market Report 2023 to 2030: Increasing Prevalence of Target Diseases Drives Growth
March 14, 2023 12:18 ET
|
Research and Markets
Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration, Diabetic Retinopathy), By Dosage Form, By...
Fundus Camera Global Market Report 2023: Increasing Number of Product Launches by Key Players is Expected to Propel Growth
March 01, 2023 09:48 ET
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Fundus Camera Market, by Product Type, by Modality, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...
Clinical trials results demonstrate value of home OCT at international meetings
February 22, 2023 08:00 ET
|
Notal Vision
Manassas, VA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be...
Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update
February 21, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling in Germany/Switzerland Basel, Switzerland, 20 February 2023. Kinarus Therapeutics...